✦ LIBER ✦

Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)

✍ Scribed by Eun Yoon Cho; Myung Hee Chang; Yoon La Choi; Jeong Eon Lee; Seok Jin Nam; Jung-Hyun Yang; Yeon Hee Park; Jin Seok Ahn; Young-Hyuck Im

Publisher: Springer
Year: 2010
Tongue: English
Weight: 532 KB
Volume: 68
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1548-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BRCA1 and EGFR as prognostic biomarkers

BRCA1 and EGFR as prognostic biomarkers in triple negative metastatic breast cancer patients treated with cisplatin plus docetaxel

✍ Lobna R. Ezz Elarab; Manal El Mahdy; Khaled Abdel Karim 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 437 KB

The wnt/β-catenin signaling pathway: A p

The wnt/β-catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer

✍ Taj D. King; Mark J. Suto; Yonghe Li 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB 👁 1 views

Predictive factors for the effectiveness

Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients

✍ Hiroko Masuda; Norikazu Masuda; Yoshinori Kodama; Masami Ogawa; Michiko Karita; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 323 KB

Quantitative microscopical and confocal

Quantitative microscopical and confocal laser scanning microscopy for intermediate endpoint biomarkers in breast cancer: Potential and reproducibility

✍ Jan P. A. Baak; S. Makkink-Nombrado; Paulos Tekola; Elisabeth Bergers; Jeroen A. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 729 KB

Diagnostic quantitative pathological (QP) determinations are increasingly used in our hospital. The number of requests for QP for reference materials is rising rapidly. This is understandable; quantitative assessments have a strong prognostic value and can be very reproducible, depending on the care

Discriminatory accuracy and potential cl

Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women

✍ E. Comen; L. Balistreri; M. Gönen; A. Dutra-Clarke; M. Fazio; J. Vijai; Z. Stadl 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 383 KB

PARP-1 expression in breast cancer inclu

PARP-1 expression in breast cancer includingBRCA1-associated, triple negative and basal-like tumors: possible implications for PARP-1 inhibitor therapy

✍ Pawel Domagala; Tomasz Huzarski; Jan Lubinski; Karol Gugala; Wenancjusz Domagala 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 428 KB